Skip to main content
. 2020 Sep 25;10:542005. doi: 10.3389/fonc.2020.542005

TABLE 1.

Demographic and tumor characteristics for entire cohort.

Characteristics All (%) Patients with <6 LNs examined (%) Patients with ≥6 LNs examined (%) P value
Total No. 1723 1353 370
Age, years <0.001
Median (range) 68 (21–96) 69 (22–96) 65 (21–91)
Sex 0.879
Male 516 (29.9%) 404 (29.9%) 112 (30.3%)
Female 1207 (70.1%) 949 (70.1%) 258 (69.7%)
Race 0.762
White 1338 (77.7%) 1049 (77.5%) 289 (78.1%)
Black 191 (11.1%) 148 (11.0%) 43 (11.6%)
Others 194 (11.2%) 156 (11.5%) 38 (10.3%)
Grade 0.533
I + II 1004 (58.3%) 779 (57.6%) 225 (60.8%)
III + IV 603 (35.0%) 481 (35.6%) 122 (33.0%)
Unknown 116 (6.7%) 93 (6.8%) 23 (6.2%)
Stage <0.001
I 226 (13.1%) 193 (14.3%) 33 (8.9%)
II 443 (25.7%) 341 (25.2%) 102 (27.6%)
III 924 (53.6%) 758 (56.0%) 166 (44.9%)
IV 130 (7.6%) 61 (4.5%) 69 (18.6%)
Histological type 0.763
Adenocarcinoma 1576 (91.5%) 1239 (91.6%) 337 (91.1%)
Other* 147 (8.5%) 114 (8.4%) 33 (8.9%)
No. of LNs examined <0.001
Mean 3.8 1.9 10.7

*Including cystic, mucinous and serous neoplasms, and epithelial neoplasms, etc.